Submissions from 2017
Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation, Minesh Mehta
State of the art: the evolving role of RT in combined modality therapy for GBM, Minesh Mehta
The role of radiation in treating glioblastoma: here to stay, Minesh Mehta
The three paradigm shifts of the 1980s and the AAS, Michael Zinner
Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper, John Paul Diaz and Jeffrey Boyd
The Changing Role of Whole-Brain Radiotherapy: Demise or Time for Selective Usage?, Minesh Mehta
The Next Journey: Moving Forward After Cancer Diagnosis and Treatment, Jane Arboleda
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases, Minesh Mehta
A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients, Michael Chuong and Minesh Mehta
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options, Yazmin Odia
The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings, Michael Chuong
Robotic assisted lobectomy for locally advanced lung cancer, Mark Dylewski
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer, Minesh Mehta and Michael Chuong
Advance Care Planning: A Window to Palliative Care, Suleyki Medina
The Collaborative Support Model: A Unique Process to On-board Oncology Infusion Nurses, Diane Kramer, Kayce Tugg, Alice Cockerel, and Charlene Mears
BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors, Ashley Roque and Yazmin Odia
Integrative Oncology: A Paradigm Shift, Yoon-Hang "John" Kim
Performance of a Web-based Method for Generating Synoptic Reports, Mercy Mena-Allauca, Patricia Carrion, Xiaorong Mei, Arniris Narciandi, Edwin Gould, and Andrew Renshaw